Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Thompson

Showing results (51-60 of 80) with videos related to

Pageof 8
Sort By:
Urology|January 8, 2013
Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysisMichael Kennelly, Roger Dmochowski, Karen Ethans, et al.
Human Gene Therapy|August 26, 2010
α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectorsLiqun Zhang, Maria P Limberis, Catherine Thompson, et al.
Human Resources for Health|June 2, 2009
Task-shifting HIV counselling and testing services in Zambia: the role of lay counsellorsParsa Sanjana, Kwasi Torpey, Alison Schwarzwalder, et al.
Virology|May 3, 2025
Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epitheliumDorothee Reuss, Jonathan C Brown, Ksenia Sukhova, et al.
The Journal of Urology|April 17, 2012
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivityDavid Ginsberg, Angelo Gousse, Veronique Keppenne, et al.
Journal of Medical Virology|November 2, 2020
An outbreak of adenovirus D8 keratoconjunctivitis in Leicester, United Kingdom, from March to August 2019Oliver T R Toovey, Priti Kulkarni, Joicy David, et al.
Vaccine|June 3, 2008
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvantsKatarina Radosević, Ariane Rodriguez, Ratna Mintardjo, et al.
European Urology|April 3, 2012
OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trialClare J Fowler, Stephen Auerbach, David Ginsberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2016
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trialsOrazio Caffo, Catherine Thompson, Maria De Santis, et al.
Frontiers in Neurology|November 22, 2021
Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral PalsyJoyce Oleszek, Ann Tilton, Jorge Carranza Del Rio, et al.
Pageof 8

Showing results (51-60 of 80) with videos related to

Sort By:
Pageof 8
Urology|January 8, 2013
Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysisMichael Kennelly, Roger Dmochowski, Karen Ethans, et al.
Human Gene Therapy|August 26, 2010
α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectorsLiqun Zhang, Maria P Limberis, Catherine Thompson, et al.
Human Resources for Health|June 2, 2009
Task-shifting HIV counselling and testing services in Zambia: the role of lay counsellorsParsa Sanjana, Kwasi Torpey, Alison Schwarzwalder, et al.
Virology|May 3, 2025
Interference between SARS-CoV-2 and influenza B virus during coinfection is mediated by induction of specific interferon responses in the lung epitheliumDorothee Reuss, Jonathan C Brown, Ksenia Sukhova, et al.
The Journal of Urology|April 17, 2012
Phase 3 efficacy and tolerability study of onabotulinumtoxinA for urinary incontinence from neurogenic detrusor overactivityDavid Ginsberg, Angelo Gousse, Veronique Keppenne, et al.
Journal of Medical Virology|November 2, 2020
An outbreak of adenovirus D8 keratoconjunctivitis in Leicester, United Kingdom, from March to August 2019Oliver T R Toovey, Priti Kulkarni, Joicy David, et al.
Vaccine|June 3, 2008
Antibody and T-cell responses to a virosomal adjuvanted H9N2 avian influenza vaccine: impact of distinct additional adjuvantsKatarina Radosević, Ariane Rodriguez, Ratna Mintardjo, et al.
European Urology|April 3, 2012
OnabotulinumtoxinA improves health-related quality of life in patients with urinary incontinence due to idiopathic overactive bladder: a 36-week, double-blind, placebo-controlled, randomized, dose-ranging trialClare J Fowler, Stephen Auerbach, David Ginsberg, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 11, 2016
Concurrent gemcitabine and radiotherapy for the treatment of muscle-invasive bladder cancer: A pooled individual data analysis of eight phase I-II trialsOrazio Caffo, Catherine Thompson, Maria De Santis, et al.
Frontiers in Neurology|November 22, 2021
Muscle Selection and Dosing in a Phase 3, Pivotal Study of AbobotulinumtoxinA Injection in Upper Limb Muscles in Children With Cerebral PalsyJoyce Oleszek, Ann Tilton, Jorge Carranza Del Rio, et al.
Pageof 8